Clinical Trial

PheCheck™ Validation Study

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to evaluate the performance of the PheCheck™ test for the rapid detection of phenylalanine (Phe) from a fingerstick sample, in patients 1 year or older with phenylketonuria (PKU) or hyperphenylalaninemia. The main objective is comparing the concentration of phenylalanine (Phe) in capillary blood with the reference method (DBS).
Trial Details
NCT Number NCT07551921
Lead Sponsor Aptatek BioSciences, Inc
Conditions Phenylketonuria (PKU) and Hyperphenylalaninemia
Enrollment 60 participants
Start Date 2026-05-20
Primary Completion 2026-12-15 (estimated)
Study Completion 2027-03-15 (estimated)
Updated on ClinicalTrials.gov 2026-04-27